Nordic market access experts
We're a team of senior Nordic market access experts with a unique combination of health economic, medical, commercial, and analytical capabilities
The Macanda team has long backgrounds from the pharmaceutical industry, market access consulting, academia, and payer / HTA agencies in the Nordic countries. With a combined experience of more than 400 market access projects delivered, the team provides solutions to clients with complex market access demands in the biotech, pharmaceutical, and medtech industries.
Unique insights and experience from supporting innovations such as precision medicine, cell- and gene therapies (C&G), advanced therapeutic medicinal products (ATMP) and orphan drugs
High-quality access strategy development for market access in Sweden, Norway, Denmark and Finland
Expert knowledge in launch optimization, landscaping and opportunity assessment
Analytical capabilities incl. health economic modelling, biostatistics and registry-based evidence generation
Experience across the full life-cycle of medical innovations and multiple therapeutical areas
Senior consultants who can challenge and optimise your evidence generation and access plans
Our services
NORDIC REIMBURSEMENT
Access strategy development
Reimbursement submission planning and development
Negotiation and contracting support
EVIDENCE GENERATION
Health economic analysis
Real-world evidence generation & analysis
Literature reviews
EARLY MARKET ACCESS
Evidence generation plans
Landscaping and opportunity assessment
Launch strategy and readiness
